Your browser doesn't support javascript.
loading
DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes.
Kizhakeyil, Atish; Zaini, Nurmahirah Binte Mohammed; Poh, Zhi Sheng; Wong, Brandon Han Siang; Loh, Xinpeng; Ng, Aik Seng; Low, Zun Siong; Prasannan, Praseetha; Gong, Chun; Tan, Michelle Guet Khim; Nagarajan, Chandramouli; Huang, Dachuan; Lu, Pang Wan; Lim, Jing Quan; Barrans, Sharon; Ong, Choon Kiat; Lim, Soon Thye; Chng, Wee Joo; Follows, George; Hodson, Daniel J; Du, Ming Qing; Goh, Yeow Tee; Tan, Suat Hoon; Grigoropoulos, Nicholas Francis; Verma, Navin Kumar.
Afiliação
  • Kizhakeyil A; Lee Kong Chian School of Medicine, Nanyang Technological University Singapore, 11 Mandalay Road, Clinical Sciences Building, Singapore, 308232, Singapore.
  • Zaini NBM; Department of Haematology, Singapore General Hospital, The Academia, Level 3, 20 College Road, Singapore, 169856, Singapore.
  • Poh ZS; Lee Kong Chian School of Medicine, Nanyang Technological University Singapore, 11 Mandalay Road, Clinical Sciences Building, Singapore, 308232, Singapore.
  • Wong BHS; Lee Kong Chian School of Medicine, Nanyang Technological University Singapore, 11 Mandalay Road, Clinical Sciences Building, Singapore, 308232, Singapore.
  • Loh X; School of Biological Sciences, Nanyang Technological University Singapore, 60 Nanyang Dr, Singapore, 637551, Singapore.
  • Ng AS; Lee Kong Chian School of Medicine, Nanyang Technological University Singapore, 11 Mandalay Road, Clinical Sciences Building, Singapore, 308232, Singapore.
  • Low ZS; Lee Kong Chian School of Medicine, Nanyang Technological University Singapore, 11 Mandalay Road, Clinical Sciences Building, Singapore, 308232, Singapore.
  • Prasannan P; Lee Kong Chian School of Medicine, Nanyang Technological University Singapore, 11 Mandalay Road, Clinical Sciences Building, Singapore, 308232, Singapore.
  • Gong C; Wellcome MRC Cambridge Stem Cell Institute, Cambridge, UK.
  • Tan MGK; Clinical Translational Sciences, Singapore General Hospital, The Academia Level 9, 20 College Road, Singapore, 169856, Singapore.
  • Nagarajan C; Department of Haematology, Singapore General Hospital, The Academia, Level 3, 20 College Road, Singapore, 169856, Singapore.
  • Huang D; Lymphoma Genomic Translational Research Laboratory, Division of Cellular and Molecular Research, National Cancer Centre Singapore, 11 Hospital Drive, Singapore, 169610, Singapore.
  • Lu PW; Lymphoma Genomic Translational Research Laboratory, Division of Cellular and Molecular Research, National Cancer Centre Singapore, 11 Hospital Drive, Singapore, 169610, Singapore.
  • Lim JQ; Lymphoma Genomic Translational Research Laboratory, Division of Cellular and Molecular Research, National Cancer Centre Singapore, 11 Hospital Drive, Singapore, 169610, Singapore.
  • Barrans S; Haematological Malignancy Diagnostic Service (HMDS), St. James's Institute of Oncology, Leeds, UK.
  • Ong CK; Lymphoma Genomic Translational Research Laboratory, Division of Cellular and Molecular Research, National Cancer Centre Singapore, 11 Hospital Drive, Singapore, 169610, Singapore.
  • Lim ST; Cancer and Stem Cell Biology, Duke-NUS Medical School, 8 College Road, Singapore, 169857, Singapore.
  • Chng WJ; Genome Institute of Singapore, 60 Biopolis Street Genome, Singapore, 138672, Singapore.
  • Follows G; Director's office, National Cancer Centre Singapore, 11 Hospital Drive, Singapore, 169610, Singapore.
  • Hodson DJ; Office of Education, Duke-NUS Medical School, 8 College Road, Singapore, 169857, Singapore.
  • Du MQ; National University Cancer Institute, Singapore, Singapore.
  • Goh YT; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
  • Tan SH; NUS Center for Cancer Research (N2CR) and Dept of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Grigoropoulos NF; Addenbrooke's Hospital NHS Foundation Trust, Cambridge, UK.
  • Verma NK; Wellcome MRC Cambridge Stem Cell Institute, Cambridge, UK.
Mol Cancer ; 20(1): 134, 2021 10 16.
Article em En | MEDLINE | ID: mdl-34654425
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Linfoma Difuso de Grandes Células B / Resistencia a Medicamentos Antineoplásicos / RNA Helicases DEAD-box Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Mol Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Singapura País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Linfoma Difuso de Grandes Células B / Resistencia a Medicamentos Antineoplásicos / RNA Helicases DEAD-box Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Mol Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Singapura País de publicação: Reino Unido